PineBridge Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-73,723
Closed -$7.32M 1241
2019
Q3
$7.32M Buy
73,723
+13,080
+22% +$1.24M 0.12% 200
2019
Q2
$5.61M Buy
60,643
+55,162
+1,006% +$5.24M 0.09% 233
2019
Q1
$518K Sell
5,481
-79
-1% -$6.91K 0.01% 704
2018
Q4
$356K Buy
5,560
+305
+6% +$22.5K 0.01% 752
2018
Q3
$470K Sell
5,255
-10,252
-66% -$906K 0.01% 755
2018
Q2
$1.23M Sell
15,507
-17,139
-52% -$1.42M 0.03% 551
2018
Q1
$2.91M Buy
32,646
+4,342
+15% +$417K 0.07% 244
2017
Q4
$2.95M Sell
28,304
-7,056
-20% -$796K 0.08% 234
2017
Q3
$5.16M Buy
35,360
+16,162
+84% +$2.2M 0.12% 158
2017
Q2
$2.49M Buy
19,198
+28
+0.1% +$3.43K 0.07% 236
2017
Q1
$2.38M Buy
19,170
+13,093
+215% +$1.57M 0.06% 261
2016
Q4
$703K Buy
6,077
+2,825
+87% +$315K 0.02% 532
2016
Q3
$340K Sell
3,252
-1,009
-24% -$109K 0.02% 348
2016
Q2
$421K Buy
4,261
+3,530
+483% +$365K 0.02% 307
2016
Q1
$73K Buy
731
+68
+10% +$7K ﹤0.01% 822
2015
Q4
$79K Sell
663
-9,588
-94% -$1.11M ﹤0.01% 836
2015
Q3
$1.11M Buy
10,251
+9,477
+1,224% +$1.18M 0.05% 234
2015
Q2
$90K Buy
774
+699
+932% +$79.9K ﹤0.01% 792
2015
Q1
$9K Buy
75
+22
+42% +$2.63K ﹤0.01% 1082
2014
Q4
$6K Buy
+53
New +$5.59K ﹤0.01% 1102
2014
Q2
Sell
-14,998
Closed -$1.05M 1156
2014
Q1
$1.05M Buy
14,998
+6,720
+81% +$532K 0.03% 286
2013
Q4
$699K Buy
8,278
+176
+2% +$13.9K 0.02% 382
2013
Q3
$624K Buy
8,102
+6,936
+595% +$486K 0.02% 348
2013
Q2
$68K Buy
+1,166
New +$70.2K ﹤0.01% 834

Other funds holding CELG

PineBridge Investments's CELG Position: Q4 2019 in Review

PineBridge Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 73,723 shares — an estimated $7.32M sold.

PineBridge Investments first reported a position in CELG in Q2 2013 and held it in 24 quarters. The position peaked at $7.32M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • PineBridge Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • PineBridge Investments sold 73,723 Celgene Corp shares in Q4 2019, an estimated $7.32M.
  • PineBridge Investments first reported a position in Celgene Corp in Q2 2013 and held it in 24 quarters.
  • PineBridge Investments's Celgene Corp position peaked at $7.32M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on PineBridge Investments's 13F filing for Q4 2019, filed 13 Feb 2020.